Literature DB >> 3180608

I-131 metaiodobenzylguanidine uptake in a parathyroid adenoma.

R S Hayward1, C K Bowering, R S Warshawski.   

Abstract

We describe a patient with multicentric small bowel carcinoids, severe hypertension, primary hyperparathyroidism, and multiple parathyroid adenomas. Intense uptake of I-131 metaiodobenzylguanidine (MIBG) occurred in a parathyroid adenoma. There was no biochemical evidence of catecholamine secretion by the tumor but elevated serum levels of parathyroid hormone were demonstrated. We suspect that occasional parathyroid adenomas, like other APUDomas, may give false positive results when MIBG imaging is used to search for pheochromocytomas. This observation supports the inclusion of the parathyroid chief cells in the amine precursor uptake and decarboxylation (APUD) cell system.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3180608     DOI: 10.1097/00003072-198809000-00002

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  2 in total

1.  Retroperitoneal malignant fibrous histiocytoma mimicking pheochromocytoma.

Authors:  Sandra Pekic; Svetozar Damjanovic; Marina Djurovic; Mirjana Doknic; Milan Petakov; Dragana Miljic; Zorka Milovanovic; Kalman Kovacs; Vera Popovic
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

Review 2.  Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

Authors:  C A Hoefnagel
Journal:  Eur J Nucl Med       Date:  1994-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.